-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Evome Medical Technologies Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2020 to Q4 2023.
- Evome Medical Technologies Inc. Amortization of Intangible Assets for the quarter ending December 31, 2023 was CA$389K, a 28.7% increase year-over-year.
- Evome Medical Technologies Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2023 was CA$1.48M, a 45.2% increase year-over-year.
- Evome Medical Technologies Inc. annual Amortization of Intangible Assets for 2023 was CA$1.48M.
- Evome Medical Technologies Inc. annual Amortization of Intangible Assets for 2021 was CA$448K.
Amortization of Intangible Assets, Trailing 12 Months (CAD)
Amortization of Intangible Assets, Quarterly (CAD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)